• By Jessica Profato, MS, CGC
• Posted December 6, 2017

How Ambry Affected Hereditary Cancer Testing in 2017

It has been an exciting and busy year at Ambry Genetics, packed with steps forward on our path towards understanding all human disease. We have continued our dedication, not only to quality testing, but to innovation, research, and patient advocacy. As we reach the end of 2017, we look forward to an even more impactful 2018 and working together…